Thermo Fisher Scientific (TMO) Current Assets (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Current Assets for 18 consecutive years, with $23.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 4.96% year-over-year to $23.4 billion; the trailing twelve-month figure through Jun 2026 stood at $23.4 billion (down 4.96% YoY), and the FY2025 full-year result was $28.7 billion, up 29.68% from the prior year.
• Current Assets grew to $23.4 billion in Q2 2026 per TMO's latest filing, from $22.3 billion in the prior quarter.
• Across five years, Current Assets topped out at $28.7 billion in Q4 2025 and bottomed at $18.1 billion in Q3 2022.
• Historically, Current Assets has averaged $22.7 billion across 5 years, with a median of $23.2 billion in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Assets decreased 21.94% in 2022, then climbed 29.68% in 2025.
• Over 5 years, Current Assets stood at $25.2 billion in 2022, then dropped by 2.54% to $24.6 billion in 2023, then decreased by 9.97% to $22.1 billion in 2024, then gained by 29.68% to $28.7 billion in 2025, then dropped by 18.61% to $23.4 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $23.4 billion, $22.3 billion, and $28.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.